{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,7]],"date-time":"2026-11-07T11:47:39Z","timestamp":1794052059768,"version":"4.8.0"},"reference-count":30,"publisher":"Harborside Press, LLC","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,4]]},"abstract":"<jats:p><jats:bold>Background:<\/jats:bold> The current AJCC TNM staging system for medullary thyroid cancer (MTC) is largely adapted from criteria for differentiated thyroid cancer, which may not fully capture MTC-specific prognostic factors. This study aimed to evaluate the prognostic significance of upper mediastinal lymph node metastasis (LNM) and propose corresponding modifications to the N category and staging system to improve their applicability for MTC. <jats:bold>Methods:<\/jats:bold> We conducted a population-based, retrospective study enrolling patients with MTC from 19 Chinese referral centers. Demographics and pathologic characteristics were collected, and patients were categorized into 4 LNM subgroups: no LNM, central cervical LNM, lateral cervical LNM, and upper mediastinal (level VII) LNM. We assessed their prognostic significance using Kaplan-Meier survival curves and Cox regression analysis. Recursive partitioning analysis was then applied to regroup patients with similar overall survival (OS). To validate our findings, we analyzed an independent cohort from the SEER database. <jats:bold>Results:<\/jats:bold> Our multicenter cohort included 827 patients with initially treated MTC, of whom 438 (53.0%) were female, with a median age of 50 years (IQR, 40\u201359). Upper mediastinal (level VII) LNM was present in 12.6% of patients and was significantly associated with worse OS, structural recurrence-free survival, and biochemical response compared with other LNM sites (all <jats:italic>P<\/jats:italic>&lt;.05). Based on these findings, we proposed up-classifying level VII metastases from N1a to a new category, N1c, while keeping the T and M definitions unchanged. We then regrouped 4 TNM stages: stage I (T1\u20132N0\u20131aM0), stage II (T1\u20133N1bM0, T3N0\u20131aM0), stage III (T4N0\u20131bM0, T1\u20133N1cM0), and stage IV (T4N1cM0, T1\u20134N0\u20131cM1). Our modified staging system demonstrated superior prognostic discrimination and predictive power compared with the current AJCC TNM system, both in our multicenter cohort and the SEER validation cohort. <jats:bold>Conclusions:<\/jats:bold> For the first time, we identified the upper mediastinum as the most critical site for regional LNM in MTC. Our proposed adjustments to the N category and TNM staging system could provide better risk stratification for patients with MTC, potentially guiding improved clinical management and treatment strategies.<\/jats:p>","DOI":"10.6004\/jnccn.2024.7095","type":"journal-article","created":{"date-parts":[[2025,3,13]],"date-time":"2025-03-13T16:04:23Z","timestamp":1741881863000},"source":"Crossref","is-referenced-by-count":5,"title":["Revised Perspective on the AJCC Staging System for Medullary Thyroid Cancer: A Study of Two Nationwide Cohorts"],"prefix":"10.6004","volume":"23","author":[{"given":"Cenkai","family":"Shen","sequence":"first","affiliation":[{"name":"Department of Head and Neck Surgery, Fudan University Shanghai Cancer Center; Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuxin","family":"Du","sequence":"additional","affiliation":[{"name":"Department of Head and Neck Surgery, Fudan University Shanghai Cancer Center; Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shiyu","family":"Xiang","sequence":"additional","affiliation":[{"name":"Department of Radiology, Fudan University Shanghai Cancer Center, Shanghai, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zimeng","family":"Li","sequence":"additional","affiliation":[{"name":"Department of Head and Neck Surgery, Fudan University Shanghai Cancer Center; Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chuqiao","family":"Liu","sequence":"additional","affiliation":[{"name":"Department of Head and Neck Surgery, Fudan University Shanghai Cancer Center; Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhiyan","family":"Liu","sequence":"additional","affiliation":[{"name":"Department of Pathology, Shanghai Sixth People\u2019s Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yijun","family":"Wu","sequence":"additional","affiliation":[{"name":"Department of Thyroid Surgery, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liang","family":"Guo","sequence":"additional","affiliation":[{"name":"Department of Head and Neck Surgery, Institute of Cancer Research and Basic Medical Sciences of Chinese Academy of Sciences, Cancer Hospital of University of Chinese Academy of Sciences, Zhejiang Cancer Hospital, Hangzhou, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of Head and Neck Surgery, Institute of Cancer Research and Basic Medical Sciences of Chinese Academy of Sciences, Cancer Hospital of University of Chinese Academy of Sciences, Zhejiang Cancer Hospital, Hangzhou, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hao","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of Thyroid Surgery, The First Hospital of China Medical University, Shenyang, Liaoning, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chuang","family":"Chen","sequence":"additional","affiliation":[{"name":"Department of Breast and Thyroid Surgery, Renmin Hospital of Wuhan University, Wuhan, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Min","family":"Yin","sequence":"additional","affiliation":[{"name":"Department of Head and Neck Surgery, Fudan University Shanghai Cancer Center; Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haitao","family":"Tang","sequence":"additional","affiliation":[{"name":"Department of Head and Neck Surgery, Fudan University Shanghai Cancer Center; Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qinghai","family":"Ji","sequence":"additional","affiliation":[{"name":"Department of Head and Neck Surgery, Fudan University Shanghai Cancer Center; Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenjun","family":"Wei","sequence":"additional","affiliation":[{"name":"Department of Head and Neck Surgery, Fudan University Shanghai Cancer Center; Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiao","family":"Shi","sequence":"additional","affiliation":[{"name":"Department of Head and Neck Surgery, Fudan University Shanghai Cancer Center; Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Head and Neck Surgery, Fudan University Shanghai Cancer Center; Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"4047","reference":[{"key":"B1","series-title":"Thyroid","first-page":"567","article-title":"Revised American Thyroid Association guidelines for the management of medullary thyroid carcinoma","volume":"25","author":"Wells SA Jr","year":"2015","unstructured":"Wells SA Jr, Asa SL, Dralle H,  Revised American Thyroid Association guidelines for the management of medullary thyroid carcinoma. Thyroid 2015;25:567\u2013610."},{"key":"B2","series-title":"Cancer","first-page":"564","article-title":"Prognostic factors for thyroid carcinoma. A population-based study of 15,698 cases from the Surveillance, Epidemiology and End Results (SEER) program 1973\u20131991","volume":"79","author":"Gilliland FD","year":"1997","unstructured":"Gilliland FD, Hunt WC, Morris DM,  Prognostic factors for thyroid carcinoma. A population-based study of 15,698 cases from the Surveillance, Epidemiology and End Results (SEER) program 1973\u20131991. Cancer 1997;79:564\u2013573."},{"key":"B3","series-title":"Cancer","first-page":"1139","article-title":"Medullary thyroid carcinoma: clinical characteristics, treatment, prognostic factors, and a comparison of staging systems","volume":"88","author":"Kebebew E","year":"2000","unstructured":"Kebebew E, Ituarte PH, Siperstein AE,  Medullary thyroid carcinoma: clinical characteristics, treatment, prognostic factors, and a comparison of staging systems. Cancer 2000;88:1139\u20131148."},{"key":"B4","series-title":"JAMA Surg","first-page":"869","article-title":"Rethinking the current American Joint Committee on Cancer TNM staging system for medullary thyroid cancer","volume":"152","author":"Adam MA","year":"2017","unstructured":"Adam MA, Thomas S, Roman SA,  Rethinking the current American Joint Committee on Cancer TNM staging system for medullary thyroid cancer. JAMA Surg 2017;152:869\u2013876."},{"key":"B5","series-title":"J Natl Cancer Inst","first-page":"1408","article-title":"Outcome prediction and the future of the TNM staging system","volume":"96","author":"Burke HB","year":"2004","unstructured":"Burke HB. Outcome prediction and the future of the TNM staging system. J Natl Cancer Inst 2004;96:1408\u20131409."},{"key":"B6","series-title":"Ann Surg Oncol","first-page":"1471","article-title":"The American Joint Committee on Cancer: the 7th edition of the AJCC cancer staging manual and the future of TNM","volume":"17","author":"Edge SB","year":"2010","unstructured":"Edge SB, Compton CC. The American Joint Committee on Cancer: the 7th edition of the AJCC cancer staging manual and the future of TNM. Ann Surg Oncol 2010;17:1471\u20131474."},{"key":"B7","series-title":"CA Cancer J Clin","first-page":"93","article-title":"The Eighth Edition AJCC Cancer Staging Manual: continuing to build a bridge from a population-based to a more \u201cpersonalized\u201d approach to cancer staging","volume":"67","author":"Amin MB","year":"2017","unstructured":"Amin MB, Greene FL, Edge SB,  The Eighth Edition AJCC Cancer Staging Manual: continuing to build a bridge from a population-based to a more \u201cpersonalized\u201d approach to cancer staging. CA Cancer J Clin 2017;67:93\u201399."},{"key":"B8","series-title":"CA Cancer J Clin","first-page":"55","article-title":"Differentiated and anaplastic thyroid carcinoma: major changes in the American Joint Committee on Cancer eighth edition cancer staging manual","volume":"68","author":"Perrier ND","year":"2018","unstructured":"Perrier ND, Brierley JD, Tuttle RM. Differentiated and anaplastic thyroid carcinoma: major changes in the American Joint Committee on Cancer eighth edition cancer staging manual. CA Cancer J Clin 2018;68:55\u201363."},{"key":"B9","series-title":"BMC Surg","first-page":"329","article-title":"Video mediastinoscopy-assisted superior mediastinal dissection in the treatment of thyroid carcinoma with mediastinal lymphadenopathy: preliminary results","volume":"21","author":"Song Y","year":"2021","unstructured":"Song Y, Dai L, Xu G,  Video mediastinoscopy-assisted superior mediastinal dissection in the treatment of thyroid carcinoma with mediastinal lymphadenopathy: preliminary results. BMC Surg 2021;21:329."},{"key":"B10","series-title":"Br J Surg","first-page":"695","article-title":"Prediction of biochemical cure in patients with medullary thyroid cancer","volume":"107","author":"Machens A","year":"2020","unstructured":"Machens A, Lorenz K, Dralle H. Prediction of biochemical cure in patients with medullary thyroid cancer. Br J Surg 2020;107:695\u2013704."},{"key":"B11","series-title":"J Natl Compr Canc Netw","first-page":"549","article-title":"Medullary thyroid carcinoma: management of lymph node metastases","volume":"8","author":"Moley JF","year":"2010","unstructured":"Moley JF. Medullary thyroid carcinoma: management of lymph node metastases. J Natl Compr Canc Netw 2010;8:549\u2013556."},{"key":"B12","series-title":"Thyroid","first-page":"536","article-title":"Inclusion of the number of metastatic lymph nodes in the staging system for medullary thyroid cancer: validating a modified American Joint Committee on Cancer tumor-node- metastasis staging system","volume":"32","author":"Wang Z","year":"2022","unstructured":"Wang Z, Tang C, Wang Y,  Inclusion of the number of metastatic lymph nodes in the staging system for medullary thyroid cancer: validating a modified American Joint Committee on Cancer tumor-node- metastasis staging system. Thyroid 2022;32:536\u2013543."},{"key":"B13","series-title":"J Thorac Oncol","first-page":"1007","article-title":"The International Association for the Study of Lung Cancer lung cancer staging project: proposals for revision of the TNM stage groups in the forthcoming (ninth) edition of the TNM classification for lung cancer","volume":"19","author":"Rami-Porta R","year":"2024","unstructured":"Rami-Porta R, Nishimura KK, Giroux DJ,  The International Association for the Study of Lung Cancer lung cancer staging project: proposals for revision of the TNM stage groups in the forthcoming (ninth) edition of the TNM classification for lung cancer. J Thorac Oncol 2024;19:1007\u20131027."},{"key":"B14","series-title":"J Chronic Dis","first-page":"721","article-title":"Empiric comparison of multivariate analytic techniques: advantages and disadvantages of recursive partitioning analysis","volume":"37","author":"Cook EF","year":"1984","unstructured":"Cook EF, Goldman L. Empiric comparison of multivariate analytic techniques: advantages and disadvantages of recursive partitioning analysis. J Chronic Dis 1984;37:721\u2013731."},{"key":"B15","series-title":"JAMA Surg","first-page":"e214298","article-title":"Development and validation of a modified pathologic nodal classification system for cutaneous melanoma","volume":"156","author":"Nguyen AT","year":"2021","unstructured":"Nguyen AT, Luu M, Nguyen VP,  Development and validation of a modified pathologic nodal classification system for cutaneous melanoma. JAMA Surg 2021;156:e214298."},{"key":"B16","series-title":"JAMA","first-page":"1063","article-title":"Evaluating discrimination of risk prediction models: the C statistic","volume":"314","author":"Pencina MJ","year":"2015","unstructured":"Pencina MJ, D\u2019Agostino RB Sr. Evaluating discrimination of risk prediction models: the C statistic. JAMA 2015;314:1063\u20131064."},{"key":"B17","series-title":"Brief Bioinform","first-page":"553","article-title":"Sensitivity and specificity of information criteria","volume":"21","author":"Dziak JJ","year":"2020","unstructured":"Dziak JJ, Coffman DL, Lanza ST,  Sensitivity and specificity of information criteria. Brief Bioinform 2020;21:553\u2013565."},{"key":"B18","series-title":"Stat Med","first-page":"157","article-title":"Evaluating the added predictive ability of a new marker: from area under the ROC curve to reclassification and beyond","volume":"27","author":"Pencina MJ","year":"2008","unstructured":"Pencina MJ, D\u2019Agostino RB Sr, D\u2019Agostino RB Jr,  Evaluating the added predictive ability of a new marker: from area under the ROC curve to reclassification and beyond. Stat Med 2008;27:157\u2013172."},{"key":"B19","series-title":"JAMA","first-page":"1377","article-title":"Discrimination and calibration of clinical prediction models: users\u2019 guides to the medical literature","volume":"318","author":"Alba AC","year":"2017","unstructured":"Alba AC, Agoritsas T, Walsh M,  Discrimination and calibration of clinical prediction models: users\u2019 guides to the medical literature. JAMA 2017;318:1377\u20131384."},{"key":"B20","series-title":"JAMA Surg","first-page":"876","article-title":"Improvement of TNM staging for medullary thyroid cancer","volume":"152","author":"Duh QY","year":"2017","unstructured":"Duh QY, Gosnell JE. Improvement of TNM staging for medullary thyroid cancer. JAMA Surg 2017;152:876\u2013877."},{"key":"B21","series-title":"Ann Surg Oncol","first-page":"2561","article-title":"Prognostic performance of alternative lymph node classification systems for patients with medullary thyroid cancer: a single center cohort study","volume":"29","author":"Prassas D","year":"2022","unstructured":"Prassas D, Kounnamas A, Cupisti K,  Prognostic performance of alternative lymph node classification systems for patients with medullary thyroid cancer: a single center cohort study. Ann Surg Oncol 2022;29:2561\u20132569."},{"key":"B22","series-title":"J Clin Endocrinol Metab","first-page":"4609","article-title":"Clinical validation of the prognostic stage groups of the eighth-edition TNM staging for medullary thyroid carcinoma","volume":"103","author":"Park SY","year":"2018","unstructured":"Park SY, Cho YY, Kim HI,  Clinical validation of the prognostic stage groups of the eighth-edition TNM staging for medullary thyroid carcinoma. J Clin Endocrinol Metab 2018;103:4609\u20134616."},{"key":"B23","series-title":"Oncologist","first-page":"e59","article-title":"A proposed modified staging system for medullary thyroid cancer: a SEER analysis with multicenter validation","volume":"29","author":"Wang Z","year":"2024","unstructured":"Wang Z, Fan X, Zha X,  A proposed modified staging system for medullary thyroid cancer: a SEER analysis with multicenter validation. Oncologist 2024;29:e59\u201367."},{"key":"B24","series-title":"Endocr Connect","first-page":"1","article-title":"Replication of newly proposed TNM staging system for medullary thyroid carcinoma: a nationwide study","volume":"8","author":"Mathiesen JS","year":"2019","unstructured":"Mathiesen JS, Kroustrup JP, Vestergaard P,  Replication of newly proposed TNM staging system for medullary thyroid carcinoma: a nationwide study. Endocr Connect 2019;8:1\u20137."},{"key":"B25","series-title":"Br J Surg","first-page":"709","article-title":"Prediction of mediastinal lymph node metastasis in medullary thyroid carcinoma","volume":"91","author":"Machens A","year":"2004","unstructured":"Machens A, Holzhausen HJ, Dralle H. Prediction of mediastinal lymph node metastasis in medullary thyroid carcinoma. Br J Surg 2004;91:709\u2013712."},{"key":"B26","series-title":"Cancer","first-page":"358","article-title":"Surgery for lymph node metastases of medullary thyroid carcinoma: a review","volume":"122","author":"Jin LX","year":"2016","unstructured":"Jin LX, Moley JF. Surgery for lymph node metastases of medullary thyroid carcinoma: a review. Cancer 2016;122:358\u2013366."},{"key":"B27","series-title":"Am J Surg","first-page":"702","article-title":"Significance of mediastinal lymph node metastases in carcinoma of the thyroid","volume":"123","author":"Block MA","year":"1972","unstructured":"Block MA, Miller JM, Horn RC Jr. Significance of mediastinal lymph node metastases in carcinoma of the thyroid. Am J Surg 1972;123:702\u2013705."},{"key":"B28","series-title":"Arch Surg","first-page":"663","article-title":"Need for a revised staging consensus in medullary thyroid carcinoma","volume":"144","author":"Boostrom SY","year":"2009","unstructured":"Boostrom SY, Grant CS, Thompson GB,  Need for a revised staging consensus in medullary thyroid carcinoma. Arch Surg 2009;144:663\u2013669."},{"key":"B29","series-title":"Eur J Surg Oncol","first-page":"2023","article-title":"The prognostic value of lymph node ratio in medullary thyroid carcinoma: a multi-center study","volume":"46","author":"Rozenblat T","year":"2020","unstructured":"Rozenblat T, Hirsch D, Robenshtok E,  The prognostic value of lymph node ratio in medullary thyroid carcinoma: a multi-center study. Eur J Surg Oncol 2020;46:2023\u20132028."},{"key":"B30","series-title":"Head Neck","first-page":"577","article-title":"Nodal disease burden and outcome of medullary thyroid carcinoma","volume":"43","author":"Moses LE","year":"2021","unstructured":"Moses LE, Oliver JR, Rotsides JM,  Nodal disease burden and outcome of medullary thyroid carcinoma. Head Neck 2021;43:577\u2013584."}],"container-title":["Journal of the National Comprehensive Cancer Network"],"original-title":[],"link":[{"URL":"https:\/\/jnccn.org\/view\/journals\/jnccn\/23\/4\/article-e247095.xml","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/jnccn.org\/downloadpdf\/journals\/jnccn\/23\/4\/article-e247095.xml","content-type":"text\/html","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/jnccn.org\/downloadpdf\/journals\/jnccn\/23\/4\/article-e247095.xml","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,9]],"date-time":"2025-04-09T12:46:31Z","timestamp":1744202791000},"score":1,"resource":{"primary":{"URL":"https:\/\/jnccn.org\/view\/journals\/jnccn\/23\/4\/article-e247095.xml"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4]]},"references-count":30,"journal-issue":{"issue":"4"},"URL":"https:\/\/doi.org\/10.6004\/jnccn.2024.7095","relation":{},"ISSN":["1540-1405","1540-1413"],"issn-type":[{"value":"1540-1405","type":"print"},{"value":"1540-1413","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,4]]}}}